How the issue of affordability is addressed around Europe was discussed at the Association of the British Pharmaceutical Industry’s (ABPI) annual conference in 24 April 2015
The future of R&D and how it can be adapted to improve the affordability of medicines was discussed at the Association of the British Pharmaceutical Industry’s 24 April 2015
Affordability of medicines was the topic of the day at the Association of the British Pharmaceutical Industry’s (ABPI) annual conference in London today. 23 April 2015
German family-owned drug major Boehringer Ingelheim has been in the biosimilars business since the end of 2011 when it developed what was effectively a startup 2 March 2015
In the opening sessions at the Genesis One Nucleus 2014 conference, the main themes and areas of interest were outlined as personalized medicine economics and b 10 December 2014
With so many balls to juggle in the development pathway of a new drug, pharma companies looking for support along the research process often find value in calli 8 December 2014
In one of the opening sessions, cloud-based life sciences provider Veeva’s co-founder and president Matt Wallach asserted that “transparency will force you to u 5 December 2014
John Andrews, consultant editor of The Economist, opened the Global Crisis of Depression conference by citing the 92 billion euro ($115 billion) annual cost to 27 November 2014
The breakthrough achieved by Dutch bacterial specialist Micreos is the most promising development the sector has seen in decades, as the company has this week l 7 November 2014
An orphan drug could offer real hope to patients with rare thyroid cancer, Japanese drugmaker Eisai revealed at the European Society for Medical Oncology’s cong 30 September 2014
Intellectual Property can be vital for the success of any pharmaceutical invention. It is very important to protect your ideas, inventions and creations to prev 29 September 2014
Diabetes is a firm priority of UK-based pharma major AstraZeneca and is in no danger of being side-lined.according to the firm’s UK marketing director Chris Bou 29 September 2014
Pharmaceutical companies have widely adopted strategies to outsource elements of their business operations.as part of an ongoing drive to deliver a more flexibl 19 September 2014
Tim White is head of global customer interaction at Lundbeck. We spoke to him at the EyeForPharma Multichannel Marketing Summit about how his role can be integr 19 September 2014
Mergers and acquisitions may excite the markets and shareholders on both sides but their record of success in delivering the anticipated benefits is not good, w 19 August 2014
As big data plays an increasing role in drug development and clinical trials.The Pharma Letter’s Bethany Rutter spoke to Richard Young.vice president.mid-market 15 August 2014
The pharmaceutical sector is still reeling from the latest fines imposed by the European Competition Commission as part of its crackdown on so-called ‘pay-for-d 1 August 2014
In an interview with The Pharma Letter, Thomas Hein, senior vice president of commercial and regulatory affairs for German privately-owned company Hermes Pharma 28 July 2014
Jan-Anders Karlsson, chief executive and director of UK-based biotechnology company Verona Pharma, has revealed his insights in a new video. 28 July 2014
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.